サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1341989

オリゴヌクレオチド合成市場：動向、機会、競合分析【2023-2028年】

Oligonucleotide Synthesis Market: Trends, Opportunities and Competitive Analysis [2023-2028]
出版日: | 発行: Lucintel | ページ情報: 英文 150 Pages | 納期: 3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

オリゴヌクレオチド合成市場：動向、機会、競合分析【2023-2028年】
出版日: 2023年08月10日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

オリゴヌクレオチド合成市場の動向と予測

世界のオリゴヌクレオチド合成市場は、2023年から2028年までのCAGRが16.1%で、2028年までに推定158億米ドルに達すると予測されています。この市場の主な促進要因は、製薬およびバイオテクノロジー分野における政府資金および研究投資の増加、分子診断および臨床応用における合成オリゴヌクレオチドの利用率の上昇、世界のがんおよび遺伝性疾患の発生率の上昇です。世界のオリゴヌクレオチド合成市場の将来は、病院、製薬・バイオテクノロジー企業、診断研究所、CROやCMO、学術研究機関などでのビジネスチャンスが期待できそうです。

オリゴヌクレオチド合成市場の洞察

  • Lucintelは、遺伝子発現解析や遺伝子検査を含むゲノム研究の普及の高まりと、様々な臨床サンプルの同時解析を可能にするバイオチップ（DNAチップ）の出現により、オリゴヌクレオチドが予測期間中に最も高い成長を遂げると予測しています。
  • この市場の中では、大学や学術研究機関が民間投資家と共同で、あるいは政府の支援を受けて、先進国のゲノム研究に巨額の投資を行い、ゲノム研究が活発に行われているため、学術研究機関が最大のセグメントであり続けると思われます。
  • 北米は、慢性疾患の罹患率が増加していること、多くの企業や研究機関がこの地域に存在することから、予測期間中も最大地域であり続けると思われます。

本レポートでは、以下の11の主要な質問に回答している：

  • Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
  • Q.2.どのセグメントがより速いペースで成長するのか、またその理由は？
  • Q.3.今後成長が加速すると思われる地域とその理由は？
  • Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
  • Q.5.この市場におけるビジネスリスクと競合の脅威は？
  • Q.6.この市場における新たな動向とその理由は？
  • Q.7.市場における顧客の需要の変化にはどのようなものがありますか？
  • Q.8.この市場における新たな開発と、その開発をリードしている企業は？
  • Q.9.この市場における主要企業は？主要企業は事業成長のためにどのような戦略的取り組みを進めているのか？
  • Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか？
  • Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか？

目次

第1章 エグゼクティブサマリー

第2章 世界のオリゴヌクレオチド合成市場：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 2017年から2028年までの市場動向と予測分析

  • マクロ経済動向（2017～2022年）と予測（2023～2028年）
  • 世界のオリゴヌクレオチド合成市場動向（2017-2022）と予測（2023-2028）
  • 製品別の世界のオリゴヌクレオチド合成市場
    • オリゴヌクレオチド
    • 機材・シンセサイザー
    • 試薬
    • サービス
    • 精製
  • アプリケーション別の世界のオリゴヌクレオチド合成市場
    • PCRプライマー
    • PCRアッセイとパネル
    • シーケンス
    • DNAマイクロアレイ
    • 蛍光in situハイブリダイゼーション（FISH）
  • 最終用途産業別の世界のオリゴヌクレオチド合成市場
    • 病院
    • 製薬およびバイオテクノロジー企業
    • 診断研究所
    • CROとCMO
    • 学術調査機関

第4章 2017年から2028年までの地域別の市場動向と予測分析

  • 地域別の世界のオリゴヌクレオチド合成市場
  • 北米のオリゴヌクレオチド合成市場
  • 欧州のオリゴヌクレオチド合成市場
  • アジア太平洋オリゴヌクレオチド合成市場
  • その他地域オリゴヌクレオチド合成市場

第5章 競合の分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

  • 成長機会分析
    • 製品別の世界のオリゴヌクレオチド合成市場の成長機会
    • アプリケーション別の世界のオリゴヌクレオチド合成市場の成長機会
    • 最終用途産業別の世界のオリゴヌクレオチド合成市場の成長機会
    • 地域別の世界のオリゴヌクレオチド合成市場の成長機会
  • 世界のオリゴヌクレオチド合成市場の新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界のオリゴヌクレオチド合成市場の能力拡大
    • 世界のオリゴヌクレオチド合成市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • Thermo Fisher Scientific
  • GE Healthcare
  • Dharmacon
  • Agilent Technologies
  • Bio-synthesis
  • Kaneka Eurogentec
  • Integrated DNA Technologies
  • BioAutomation
  • Biolegio
  • Twist Bioscience
目次

Oligonucleotide Synthesis Market Trends and Forecast

The future of the global oligonucleotide synthesis market looks promising with opportunities in hospitals, pharmaceutical & biotechnology companies, diagnostic laboratories, CROs and CMOs, and academic research institutes. The global oligonucleotide synthesis market is expected to reach an estimated $15.8 billion by 2028 with a CAGR of 16.1% from 2023 to 2028. The major drivers for this market are increasing government funding and research investments within the pharmaceutical and biotechnology sectors, rising utilization of synthesized oligonucleotides in molecular diagnostics and clinical applications, and rising incidence of cancer and genetic disorders globally.

A more than 150-page report is developed to help in your business decisions.

Oligonucleotide Synthesis Market by Segment

The study includes a forecast for the global oligonucleotide synthesis market by product, application, end use industry, and region, as follows:

Oligonucleotide Synthesis Market by Product [Shipment Analysis by Value from 2017 to 2028]:

  • Oligonucleotides
  • Equipment/Synthesizer
  • Reagents
  • Services
  • Purification
  • Modification

Oligonucleotide Synthesis Market by Application [Shipment Analysis by Value from 2017 to 2028]:

  • PCR Primers
  • PCR Assays and Panels
  • Sequencing
  • DNA Microarrays
  • Fluorescence In Situ Hybridization (FISH)
  • Antisense Oligonucleotides
  • Others

Oligonucleotide Synthesis Market by End Use Industry [Shipment Analysis by Value from 2017 to 2028]:

  • Hospitals
  • Pharmaceutical & Biotechnology Companies
  • Diagnostic Laboratories
  • CROs and CMOs
  • Academic Research Institutes

Oligonucleotide Synthesis Market by Region [Shipment Analysis by Value from 2017 to 2028]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Oligonucleotide Synthesis Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, oligonucleotide synthesis companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the oligonucleotide synthesis companies profiled in this report include:

  • Thermo Fisher Scientific
  • GE Healthcare
  • Dharmacon
  • Agilent Technologies
  • Bio-synthesis
  • Kaneka Eurogentec
  • Integrated DNA Technologies
  • BioAutomation
  • Biolegio
  • Twist Bioscience

Oligonucleotide Synthesis Market Insights

  • Lucintel forecasts that oligonucleotide will witness the highest growth over the forecast period due to the rising prevalence of genomic research endeavors, including gene expression analysis and genetic testing, along with the advent of biochips (DNA chips) enabling simultaneous analysis of various clinical samples.
  • Within this market, academic research institutes will remain the largest segment due to robust genomic research being conducted by universities and academic research institutes either in collaboration with private investors or with government support along with huge investments in the genomic research in developed countries.
  • North America will remain the largest region over the forecast period due to increasing incidence of chronic diseases and the substantial presence of numerous companies and research institutes in this region.

Features of the Global Oligonucleotide Synthesis Market

  • Market Size Estimates: Oligonucleotide synthesis market size estimation in terms of value ($B).
  • Trend and Forecast Analysis: Market trends (2017 to 2022) and forecast (2023 to 2028) by various segments and regions.
  • Segmentation Analysis: Oligonucleotide synthesis market size by various segments, such as by product, application, end use industry, and region in terms of value ($B).
  • Regional Analysis: Oligonucleotide synthesis market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different products, applications, end use industries, and regions for the Oligonucleotide Synthesis Market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the oligonucleotide synthesis market.
  • Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

  • Q.1. What is the oligonucleotide synthesis market size?
  • Answer: The global oligonucleotide synthesis market is expected to reach an estimated $15.8 billion by 2028.
  • Q.2. What is the growth forecast for oligonucleotide synthesis market?
  • Answer: The global oligonucleotide synthesis market is expected to grow with a CAGR of 16.1% from 2023 to 2028.
  • Q.3. What are the major drivers influencing the growth of the oligonucleotide synthesis market?
  • Answer: The major drivers for this market are increasing government funding and research investments within the pharmaceutical and biotechnology sectors, rising utilization of synthesized oligonucleotides in molecular diagnostics and clinical applications, and rising incidence of cancer and genetic disorders globally.
  • Q4. What are the major segments for oligonucleotide synthesis market?
  • Answer: The future of the global oligonucleotide synthesis market looks promising with opportunities in hospitals, pharmaceutical & biotechnology companies, diagnostic laboratories, CROs and CMOs, and academic research institutes.
  • Q5. Who are the key oligonucleotide synthesis companies?
  • Answer: Some of the key oligonucleotide synthesis companies are as follows:
    • Thermo Fisher Scientific
    • GE Healthcare
    • Dharmacon
    • Agilent Technologies
    • Bio-Synthesis
    • Kaneka Eurogentec
    • Integrated DNA Technologies
    • BioAutomation
    • Biolegio
    • Twist Bioscience
  • Q6. Which oligonucleotide synthesis market segment will be the largest in future?
  • Answer: Lucintel forecasts that oligonucleotide will witness the highest growth over the forecast period due to the rising prevalence of genomic research endeavors, including gene expression analysis and genetic testing, along with the advent of biochips (DNA chips) enabling simultaneous analysis of various clinical samples.
  • Q7. In oligonucleotide synthesis market, which region is expected to be the largest in next 5 years?
  • Answer: North America will remain the largest region over the forecast period due to increasing incidence of chronic diseases and the substantial presence of numerous companies and research institutes in this region.
  • Q.8. Do we receive customization in this report?
  • Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the oligonucleotide synthesis market by product (oligonucleotides, equipment/synthesizer, reagents, services, purification, and modification), application (PCR primers, PCR assays and panels, sequencing, DNA microarrays, fluorescence in situ hybridization (FISH), antisense oligonucleotides, and others), end use industry (hospitals, pharmaceutical & biotechnology companies, diagnostic laboratories, CROs and CMOs, and academic research institutes), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last five years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Oligonucleotide Synthesis Market: Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2017 to 2028

  • 3.1: Macroeconomic Trends (2017-2022) and Forecast (2023-2028)
  • 3.2: Global Oligonucleotide Synthesis Market Trends (2017-2022) and Forecast (2023-2028)
  • 3.3: Global Oligonucleotide Synthesis Market by Product
    • 3.3.1: Oligonucleotides
    • 3.3.2: Equipment/Synthesizer
    • 3.3.4: Reagents
    • 3.3.5: Services
    • 3.3.6: Purification
  • 3.4: Global Oligonucleotide Synthesis Market by Application
    • 3.4.1: PCR Primers
    • 3.4.2: PCR Assays and Panels
    • 3.4.3: Sequencing
    • 3.4.4: DNA Microarrays
    • 3.4.5: Fluorescence in Situ Hybridization (FISH)
  • 3.5: Global Oligonucleotide Synthesis Market by End Use Industry
    • 3.5.1: Hospitals
    • 3.5.2: Pharmaceutical & Biotechnology Companies
    • 3.5.3: Diagnostic Laboratories
    • 3.5.4: CROs and CMOs
    • 3.5.5: Academic Research Institutes

4. Market Trends and Forecast Analysis by Region from 2017 to 2028

  • 4.1: Global Oligonucleotide Synthesis Market by Region
  • 4.2: North American Oligonucleotide Synthesis Market
    • 4.2.1: North American Oligonucleotide Synthesis Market by Product: Oligonucleotide, Equipment/Synthesizer, Reagents, Services, Purification, and Modification
    • 4.2.2: North American Oligonucleotide Synthesis Market by End Use Industry: Hospitals, Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, CROs and CMOs, and Academic Research Institutes
  • 4.3: European Oligonucleotide Synthesis Market
    • 4.3.1: European Oligonucleotide Synthesis Market by Product: Oligonucleotide, Equipment/Synthesizer, Reagents, Services, Purification, and Modification
    • 4.3.2: European Oligonucleotide Synthesis Market by End Use Industry: Hospitals, Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, CROs and CMOs, and Academic Research Institutes
  • 4.4: APAC Oligonucleotide Synthesis Market
    • 4.4.1: APAC Oligonucleotide Synthesis Market by Product: Oligonucleotide, Equipment/Synthesizer, Reagents, Services, Purification, and Modification
    • 4.4.2: APAC Oligonucleotide Synthesis Market by End Use Industry: Hospitals, Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, CROs and CMOs, and Academic Research Institutes
  • 4.5: ROW Oligonucleotide Synthesis Market
    • 4.5.1: ROW Oligonucleotide Synthesis Market by Product: Oligonucleotide, Equipment/Synthesizer, Reagents, Services, Purification, and Modification
    • 4.5.2: ROW Oligonucleotide Synthesis Market by End Use Industry: Hospitals, Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, CROs and CMOs, and Academic Research Institutes

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Oligonucleotide Synthesis Market by Product
    • 6.1.2: Growth Opportunities for the Global Oligonucleotide Synthesis Market by Application
    • 6.1.3: Growth Opportunities for the Global Oligonucleotide Synthesis Market by End Use Industry
    • 6.1.4: Growth Opportunities for the Global Oligonucleotide Synthesis Market by Region
  • 6.2: Emerging Trends in the Global Oligonucleotide Synthesis Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Oligonucleotide Synthesis Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Oligonucleotide Synthesis Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Thermo Fisher Scientific
  • 7.2: GE Healthcare
  • 7.3: Dharmacon
  • 7.4: Agilent Technologies
  • 7.5: Bio-synthesis
  • 7.6: Kaneka Eurogentec
  • 7.7: Integrated DNA Technologies
  • 7.8: BioAutomation
  • 7.9: Biolegio
  • 7.10: Twist Bioscience